Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraSonic has developed a non-invasive robotic medical device that uses low-intensity focused ultrasound to transiently disrupt the blood-brain barrier, enabling targeted drug delivery to the brain. The company has raised €1 million in pre-seed funding and aims to initiate its first clinical trial soon. The technology builds on over 15 years of academic research, several patents, and more than 40 international publications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraSonic.